![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
NGM282 DEMONSTRATES ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES THAT ARE INDEPENDENT OF STEATOSIS REDUCTION IN A FARNESOIDX RECEPTOR (FXR)-DEFICIENT, DIET-INDUCED ANIMAL MODEL OF NON-ALCOHOLIC STEATOHEPATITIS(NASH)
|
|
|
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Lei Ling, Mei Zhou, Marc Learned, Stephen Rossi, Alex DePaoli, Hui Tian
NGM Biopharmaceuticals, Inc., South San Francisco, CA 94080, USA
![1214181](../images%20/121418/121418-1/1214181.gif)
![1214182](../images%20/121418/121418-1/1214182.gif)
![1214183](../images%20/121418/121418-1/1214183.gif)
![1214184](../images%20/121418/121418-1/1214184.gif)
![1214185](../images%20/121418/121418-1/1214185.gif)
![1214186](../images%20/121418/121418-1/1214186.gif)
![1214187](../images%20/121418/121418-1/1214187.gif)
![1214188](../images%20/121418/121418-1/1214188.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|